Section Arrow
LENZ.NASDAQ
- LENZ Therapeutics
Quotes are at least 15-min delayed:2025/09/12 04:14 EDT
Pre Market
Last
 40.81
0 (0.00%)
Bid
39.62
Ask
42
High 40.81 
Low 40.81 
Volume 21 
Regular Hours
Last
 40.81
-0.9 (-2.16%)
Day High 
42.02 
Prev. Close
41.71 
1-M High
42.77 
Volume 
411.46K 
Bid
39.62
Ask
42
Day Low
40.08 
Open
41.41 
1-M Low
34.88 
Market Cap 
1.19B 
Currency USD 
P/E 45.35 
%Yield 32.39 
10-SMA 39.59 
20-SMA 39.35 
50-SMA 35.35 
52-W High 42.77 
52-W Low 16.535 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.63/-2.69
Enterprise Value
1.19B
Balance Sheet
Book Value Per Share
7.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GRIGRI Bio Inc.2.05+0.49+31.41%0.02PE
Pre Market 1.78 -0.27 -13.17%
RXRXRecursion Pharmaceuticals4.85+0.31+6.83%-- 
Pre Market 4.93 +0.08 +1.65%
SLXNSilexion Therapeutics Corp4.93+0.445+9.92%-- 
Pre Market 4.92 -0.01 -0.20%
ADAPAdaptimmune Therapeutics plc0.0505-0.0003-0.59%-- 
Pre Market 0.0515 +0.001 +1.98%
ROIVRoivant Sciences Ltd14.41+0.64+4.65%1.95PE
Pre Market 14.41 0 0.00%
Quotes are at least 15-min delayed:2025/09/12 04:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, theinevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.